AstraZeneca Aktie
155,00
EUR
+0,55
EUR
+0,36
%
144,77
CHF
-0,56
CHF
-0,39
%
Werbung
AstraZeneca Aktie Analyse
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 16.07.12 | AstraZeneca buy | UBS AG | |
| 12.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
|
Werbung
|
|||
| 02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 28.06.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 21.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 20.06.12 | AstraZeneca neutral | Citigroup Corp. | |
| 19.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 11.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 08.06.12 | AstraZeneca buy | UBS AG | |
| 05.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 04.06.12 | AstraZeneca neutral | Citigroup Corp. | |
| 30.05.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.05.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 18.05.12 | AstraZeneca buy | UBS AG | |
| 10.05.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 04.05.12 | AstraZeneca buy | UBS AG | |
| 04.05.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 27.04.12 | AstraZeneca outperform | Cheuvreux SA | |
| 27.04.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 23.04.12 | AstraZeneca reduce | Nomura | |
| 30.03.12 | AstraZeneca buy | UBS AG | |
| 30.03.12 | AstraZeneca buy | UBS AG | |
| 23.03.12 | AstraZeneca buy | UBS AG | |
| 07.02.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 06.02.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 06.02.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.02.12 | AstraZeneca hold | Deutsche Bank AG | |
| 03.02.12 | AstraZeneca halten | Independent Research GmbH | |
| 01.02.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | AstraZeneca reduce | Nomura | |
| 22.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 21.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
| 16.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 15.12.11 | AstraZeneca hold | Deutsche Bank AG | |
| 13.12.11 | AstraZeneca underperform | Credit Suisse Group | |
| 09.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 08.12.11 | AstraZeneca neutral | Citigroup Corp. | |
| 30.11.11 | AstraZeneca neutral | Citigroup Corp. | |
| 03.11.11 | AstraZeneca halten | Independent Research GmbH | |
Werbung
Werbung